Drugs News and Research

RSS

Researchers highlight the importance of localizing BRCA gene mutations for better ovarian cancer treatment

Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1 in 800 people respectively, significantly increase the risk of certain cancers such as ovarian, breast, pancreatic and prostate cancer.

28 Nov 2022

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

In this interview, we speak to Axol Bioscience about their human iPSC-derived cells and how they have the potential to revolutionize the field of neurodegenerative disease.

From Axol Bioscience Ltd 28 Nov 2022

Common chemotherapy drug could carry toxic inheritance for future generations of cancer survivors

A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington State University-led research indicates.

28 Nov 2022

Researchers use a comparative study to model RSV prevention in children

Using computational modeling, a new paper compares the benefit of maternal vaccines versus the administration of respiratory syncytial virus (RSV)-specific monoclonal antibody (mAb) therapy against RSV.

28 Nov 2022

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.

27 Nov 2022

Can acupuncture alleviate lower back and pelvic pain in pregnant women?

Scientists have recently reviewed available evidence on the effectiveness and safety of acupuncture in treating lower back and/or pelvic pain during pregnancy.

25 Nov 2022

The potential of Sofosbuvir against COVID-19 neurological symptoms

Researchers discuss how SARS-CoV-2 infects cortical neurons and damages their synapses that form the connection between brain cells.

25 Nov 2022

New biomarker can help identify people with a primary tauopathy

Zooming in on a single disease and studying it intensely is often the most productive route to finding treatments. But there's no easy way to distinguish among people living with any of the primary tauopathies - a group of rare brain diseases marked by rapidly worsening problems with thinking and movement - because the symptoms are too similar.

24 Nov 2022

Novel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapy

University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study published today.

24 Nov 2022

Researchers discover how phage resistance helps drive the emergence of dominant Salmonella strains

Researchers from the Quadram Institute and the University of East Anglia have uncovered how resistance has helped drive the emergence of dominant strains of Salmonella.

24 Nov 2022

World Antimicrobial Awareness Week 2022: What is the burden of antimicrobial resistance?

As part of World Antimicrobial Resistance Week 2022, News-Medical speaks to Dr. Tomislav Meštrović about his new research discussing the burden of bacterial antimicrobial resistance in the WHO European region, as well as about how we can prevent antimicrobial resistance together.

24 Nov 2022

AI helps design synthetic DNA that controls cells' protein production

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells' protein production.

24 Nov 2022

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

Researchers described the clinical characteristics and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) in the Netherlands.

24 Nov 2022

Animal study pinpoints a gene that is vital for development of earliest social behaviors

Little is known about how social behavior develops in the earliest stages of life. But most animals––including humans––are born with an innate ability to interact socially or form bonds with others. And that contributes to success throughout life.

24 Nov 2022

Study aims to develop broad-spectrum antivirals against SARS-CoV-2 via drug repurposing strategies

This study aims to determine which FDA-approved compound(s) can be repurposed as a broad-spectrum antiviral drug(s) against SARS-CoV-2 and variants.

24 Nov 2022

What Impact is Antimicrobial Resistance having on Animal Health?

For World Antimicrobial Awareness Week 2022, we speak to Junxia Song, FAO Senior Animal Health Officer, about the impact AMR is having on animal health.

24 Nov 2022

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by The BMJ today.

24 Nov 2022

Research reveals existence of a hidden ''pocket’ on the surface of key SARS-CoV-2 protein

With the continuous emergence of new variants and the risk of new strains of the virus, the development of innovative therapies against SARS-CoV-2 remains a major public health challenge.

23 Nov 2022

New study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

23 Nov 2022

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.

23 Nov 2022

Drugs News and Research

Researchers highlight the importance of localizing BRCA gene mutations for better ovarian cancer treatment

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

Common chemotherapy drug could carry toxic inheritance for future generations of cancer survivors

Researchers use a comparative study to model RSV prevention in children

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

Can acupuncture alleviate lower back and pelvic pain in pregnant women?

The potential of Sofosbuvir against COVID-19 neurological symptoms

New biomarker can help identify people with a primary tauopathy

Novel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapy

Researchers discover how phage resistance helps drive the emergence of dominant Salmonella strains

World Antimicrobial Awareness Week 2022: What is the burden of antimicrobial resistance?

AI helps design synthetic DNA that controls cells' protein production

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

Animal study pinpoints a gene that is vital for development of earliest social behaviors

Study aims to develop broad-spectrum antivirals against SARS-CoV-2 via drug repurposing strategies

What Impact is Antimicrobial Resistance having on Animal Health?

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Research reveals existence of a hidden ''pocket’ on the surface of key SARS-CoV-2 protein

New study points to a strategy for inhibiting hyper-progression of melanoma

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News